Skip to main content
SpringerLink
Log in

Medical Management of Advanced Disease

  • Chapter
  • First Online:
Management of Breast Cancer in Older Women

  • 770 Accesses

Abstract

Breast cancer is the most common cancer site in women in the world with 1.15 million new cases, of which 3,61,000 are in Europe and 2,30,000 in North America (Parkin et al. 2005). In 2002, 4,11,000 women died of breast cancer worldwide. For women aged 65 years and older, breast cancer incidence rates are 432.7 per 1,00,000 females in North America and 295.0 per 1,00,000 in Europe; corresponding breast cancer mortality figures are 121.2 and 135.0 per 1,00,000 females, respectively. About a third of the global breast cancer cases occur in patients above age 65, and in more developed countries this is more than 40%. Breast cancer can recur many years after the initial diagnosis and treatment, so within the “metastatic breast cancer” population, the percentage of elderly women will be even higher.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Bajetta E, Procopio G, Celio L, Gattinoni L, la Torre S, Mariani L, Catena L, Ricotta R, Longarini R, Zilembo N, Buzzoni R (2005) Safety and efficacy of two different doses of capecitabine in the treatment of advanced breast cancer in older women. Journal of Clinical Oncology 23:2155-2161

    Article  PubMed  CAS  Google Scholar 

  • Barzacchi MC, Nobile MT, Sanguineti O, Sertoli MR, Chiara S, Repetto L, Forno G, Lavarello A, Rosso R (1994) Treatment of Metastatic Colorectal-Carcinoma with Lymphoblastoid Interferon and 5-Fluorouracil—Data of A Phase-Ii Study. Anticancer Research 14:2147-2149

    PubMed  CAS  Google Scholar 

  • Biganzoli L, Coleman R, Minisini A, Hamilton A, Aapro M, Therasse P, Mottino G, Bogaerts J, Piccart M (2007) A joined analysis of two European Organization for the Research and Treatment of Cancer (EORTC) studies to evaluate the role of pegylated liposomal doxorubicin (Caelyx (TM)) in the treatment of elderly patients with metastatic breast cancer. Critical Reviews in Oncology Hematology 61:84-89

    Article  Google Scholar 

  • Caralt M, Bilbao I, Cortes J, Escartin A, Lazaro JL, Dopazo C, Olsina JJ, Balsells J, Charco R (2008) Hepatic resection for liver metastases as part of the “oncosurgical” treatment of metastatic breast cancer. Ann Surg.Oncol 15:2804-2810

    Article  PubMed  Google Scholar 

  • Christman K, Muss HB, Case LD, Stanley V (1992) Chemotherapy of Metastatic Breast-Cancer in the Elderly—the Piedmont-Oncology-Association Experience. Jama-Journal of the American Medical Association 268:57-62

    Article  CAS  Google Scholar 

  • Colleoni M, Orlando L, Sanna G, Rocca A, Maisonneuve P, Peruzzotti G, Ghisini R, Sandri MT, Zorzino L, Nole F, Viale G, Goldhirsch A (2006) Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects. Ann Oncol 17:232-238

    Article  PubMed  CAS  Google Scholar 

  • Dees EC, O’Reilly S, Goodman SN, Sartorius S, Levine MA, Jones RJ, Grochow LB, Donehower RC, Fetting JH (2000) A prospective pharmacologic evaluation of age-related toxicity of adjuvant chemotherapy in women with breast cancer. Cancer Invest 18:521-529

    Article  PubMed  CAS  Google Scholar 

  • Feher O, Vodvarka P, Jassem J, Morack G, Advani SH, Khoo KS, Doval DC, Ermisch S, Roychowdhury D, Miller MA, von Minckwitz G (2005) First-line gemcitabine versus epirubicin in postmenopausal women aged 60 or older with metastatic breast cancer: a multicenter, randomized, phase III study. Annals of Oncology 16:899-908

    Article  PubMed  CAS  Google Scholar 

  • Gelman RS, Taylor SG (1984) Cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in women more than 65 years old with advanced breast cancer: the elimination of age trends in toxicity by using doses based on creatinine clearance. J Clin Oncol 2:1404-1413

    PubMed  CAS  Google Scholar 

  • Geyer CE, Forster J, Lindquist D, Chan S, Romieu CG, Pienkowski T, Jagiello-Gruszfeld A, Crown J, Chan A, Kaufman B, Skarlos D, Campone M, Davidson N, Berger M, Oliva C, Rubin SD, Stein S, Cameron D: Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N.Engl.J Med 2006, 355:2733-2743.

    Google Scholar 

  • Hainsworth JD, Burris HA III, Yardley DA, Bradof JE, Grimaldi M, Kalman LA, Sullivan T, Baker M, Erland JB, Greco FA (2001) Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase II trial. J Clin Oncol 19:3500-3505

    PubMed  CAS  Google Scholar 

  • Hamberg P, Verweij J, Seynaeve C (2007) Cytotoxic therapy for the elderly with metastatic breast cancer: A review on safety, pharmacokinetics and efficacy. European Journal of Cancer 43:1514-1528

    Article  PubMed  CAS  Google Scholar 

  • Ibrahim NK, Frye DK, Buzdar AU, Walters RS, Hortobagyi GN: Doxorubicin-based chemotherapy in elderly patients with metastatic breast cancer. Tolerance and outcome. Arch Intern.Med 1996, 156:882-888.

    Google Scholar 

  • Ibrahim NK, Hortobagyi GN, Ewer M, Ali MK, Asmar L, Theriault RL, Fraschini G, Frye DK, Buzdar AU: Doxorubicin-induced congestive heart failure in elderly patients with metastatic breast cancer, with long-term follow-up: the M.D. Anderson experience. Cancer Chemother.Pharmacol. 1999, 43:471-478.

    Google Scholar 

  • Khan SA, Stewart AK, Morrow M (2002) Does aggressive local therapy improve survival in metastatic breast cancer? Surgery 132:620-626

    Article  PubMed  Google Scholar 

  • Lichtman SM, Wildiers H, Launay-Vacher V, Steer C, Chatelut E, Aapro M (2007a) International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency. European Journal of Cancer 43:14-34

    Article  PubMed  Google Scholar 

  • Lichtman SM, Wildiers H, Chatelut E, Steer C, Budman D, Morrison VA, Tranchand B, Shapira I, Aapro M: International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients—an analysis of the medical literature. J.Clin.Oncol. 2007, 25:1832-1843.

    Google Scholar 

  • Mammoliti S, Merlini L, Caroti C, Gallo L (1996) Phase II study of mitoxantrone, 5-fluorouracil, and levo-leucovorin (MLF) in elderly advanced breast cancer patients. Breast Cancer Research and Treatment 37:93-96

    Article  PubMed  CAS  Google Scholar 

  • Milla-Santos A, Milla L, Portella J, Rallo L, Pons M, Rodes E, Casanovas J, Puig-Gali M (2003) Anastrozole versus tamoxifen as first-line therapy in postmenopausal patients with hormone-dependent advanced breast cancer—A prospective, randomized, phase III study. American Journal of Clinical Oncology-Cancer Clinical Trials 26:317-322

    CAS  Google Scholar 

  • Miller KD (2005) WMGJDMCMPESTDNE: A randomized phase III trial of paclitaxel versus paclitaxel plus bevacizumab as first-line therapy for locally recurrent or metastatic breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group (E2100) In: Abstractof the san antionio breast cancer symposium

    Google Scholar 

  • Mouridsen H, Chaudri-Ross HA (2004) Efficacy of first-line letrozole versus tamoxifen as a function of age in postmenopausal women with advanced breast cancer. Oncologist 9:497-506

    Article  PubMed  CAS  Google Scholar 

  • Mouridsen H, Gershanovich M, Sun Y, Perez-Carrion R, Boni C, Monnier A, Apffelstaedt J, Smith R, Sleeboom HP, Jaenicke F, Pluzanska A, Dank M, Becquart D, Bapsy PP, Salminen E, Snyder R, Chaudri-Ross H, Lang R, Wyld P, Bhatnagar A (2003a) Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group. J Clin Oncol 21:2101-2109

    Article  PubMed  CAS  Google Scholar 

  • Mouridsen H, Gershanovich M, Sun Y, Perez-Carrion R, Boni C, Monnier A, Apffelstaedt J, Smith R, Sleeboom HP, Jaenicke F, Pluzanska A, Dank M, Becquart D, Bapsy PP, Salminen E, Snyder R, Chaudri-Ross H, Lang R, Wyld P, Bhatnagar A: Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group. J.Clin.Oncol. 2003, 21:2101-2109.

    Google Scholar 

  • Muss HB, Case LD, Atkins JN, Bearden JD III, Cooper MR, Cruz JM, Jackson DV Jr, O’Rourke MA, Pavy MD, Powell BL (1994) Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association study. J Clin Oncol 12:1630-1638

    PubMed  CAS  Google Scholar 

  • Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108

    Article  PubMed  Google Scholar 

  • Perez EA, Vogel CL, Irwin DH, Kirshner JJ, Patel R (2002) Weekly paclitaxel in women age 65 and above with metastatic breast cancer. Breast Cancer Research and Treatment 73:85-88

    Article  PubMed  CAS  Google Scholar 

  • Poole C, Gardiner J, Twelves C, Johnston P, Harper P, Cassidy J, Monkhouse J, Banken L, Weidekamm E, Reigner B (2002) Effect of renal impairment on the pharmacokinetics and tolerability of capecitabine (Xeloda) in cancer patients. Cancer Chemotherapy and Pharmacology 49:225-234

    Article  PubMed  Google Scholar 

  • Giuliani R (2004) AMMMPJYLMRJDJPKADLMJPLB: Is age a risk factor of congestive heart failure (CHF) in patients receiving trastuzumab (H)? Results from two Belgian compassionate use programs in metastatic breast cancer (MBC) patients (pts) [abstract]. Proc Am Soc Clin Oncol 22: 838

    Google Scholar 

  • Ramalingam SS, Dahlberg SE, Langer CJ, Gray R, Belani CP, Brahmer JR, Sandler AB, Schiller JH, Johnson DH (2008) Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599. J Clin Oncol 26:60-65

    Article  PubMed  CAS  Google Scholar 

  • Rapiti E, Verkooijen HM, Vlastos G, Fioretta G, Neyroud-Caspar I, Sappino AP, Chappuis PO, Bouchardy C (2006) Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. Journal of Clinical Oncology 24:2743-2749

    Article  PubMed  Google Scholar 

  • Sheth HR, Lord G, Tkaczuk K, Danton M, Lewis LM, Langenberg P, Lim CK, Flaws JA: Aging may be associated with concentrations of tamoxifen and its metabolites in breast cancer patients. J.Womens Health (Larchmt.) 2003, 12:799-808.

    Google Scholar 

  • Skillings JR, Johnson DH, Miller K, Kabbinavar F, Bergsland E, Holmgren E, Holden SN, Hurwitz H, Scappaticci F: Arterial thromboembolic events (ATEs) in a pooled analysis of 5 randomized, controlled trials (RCTs) of bevacizurnab (BV) with chemotherapy. Journal of Clinical Oncology 2005, 23:196S.

    Google Scholar 

  • Smorenburg CH, ten Tije AJ, Verweij J, Bontenbal M, Mross K, van Zomeren DM, Seynaeve C, Sparreboom A: Altered clearance of unbound paclitaxel in elderly patients with metastatic breast cancer. Eur.J Cancer 2003, 39:196-202.

    Google Scholar 

  • Sorio R, Robieux I, Galligioni E, Freschi A, Colussi AM, Crivellari D, Saracchini S, Monfardini S (1997) Pharmacokinetics and tolerance of vinorelbine in elderly patients with metastatic breast cancer. European Journal of Cancer 33:301-303

    Article  PubMed  CAS  Google Scholar 

  • Taylor SG, Gelman RS, Falkson G, Cummings FJ (1986) Combination chemotherapy compared to tamoxifen as initial therapy for stage IV breast cancer in elderly women. Ann Intern Med 104:455-461

    Article  PubMed  Google Scholar 

  • ten Tije AJ, Verweij J, Carducci MA, Graveland W, Rogers T, Pronk T, Verbruggen MP, Dawkins F, Baker SD (2005) Prospective evaluation of the pharmacokinetics and toxicity profile of docetaxel in the elderly. Journal of Clinical Oncology 23:1070-1077

    Article  PubMed  Google Scholar 

  • Thelen A, Benckert C, Jonas S, Lopez-Hanninen E, Sehouli J, Neumann U, Rudolph B, Neuhaus P (2008) Liver resection for metastases from breast cancer. J Surg Oncol 97:25-29

    Article  PubMed  Google Scholar 

  • Vogel C, O’Rourke M, Winer E, Hochster H, Chang A, Adamkiewicz B, White R, McGuirt C (1999) Vinorelbine as first-line chemotherapy for advanced breast cancer in women 60 years of age or older. Annals of Oncology 10:397-402

    Article  PubMed  CAS  Google Scholar 

  • Wildiers H, Paridaens R (2004) Taxanes in elderly breast cancer patients. Cancer Treat Rev 30:333-342

    Article  PubMed  CAS  Google Scholar 

  • Wildiers H, Highley MS, de Bruijn EA, van Oosterom AT (2003) Pharmacology of anticancer drugs in the elderly population. Clinical Pharmacokinetics 42:1213-1242

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Medical Oncology, Uz Leuven—Gasthuisberg, Herestraat 49, B-3000, Leuven, Belgium

    Hans P. M. W. Wildiers

Authors
  1. Hans P. M. W. Wildiers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hans P. M. W. Wildiers .

Editor information

Editors and Affiliations

  1. University of Sheffield, Sheffield, S10 2JF, United Kingdom

    Malcolm W. Reed

  2. Marshalls Cross Road, St Helens, WA9 3DA, United Kingdom

    Riccardo A. Audisio

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag London

About this chapter

Cite this chapter

Wildiers, H.P.M.W. (2010). Medical Management of Advanced Disease. In: Reed, M., Audisio, R. (eds) Management of Breast Cancer in Older Women. Springer, London. https://doi.org/10.1007/978-1-84800-265-4_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-84800-265-4_19

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84800-264-7

  • Online ISBN: 978-1-84800-265-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation